Larimar Therapeutics Inc (LRMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 31,293 | 18,264 | 24,599 | 16,734 | 14,162 |
| Operating Income | -31,293 | -18,264 | -24,599 | -16,734 | -14,162 |
| Other Income | 2,469 | 2,765 | 2,972 | 2,080 | 1,169 |
| Pre-tax Income | -28,824 | -15,499 | -21,627 | -14,654 | -12,993 |
| Net Income Continuous | -28,824 | -15,499 | -21,627 | -14,654 | -12,993 |
| Net Income | $-28,824 | $-15,499 | $-21,627 | $-14,654 | $-12,993 |
| EPS Basic Total Ops | -0.47 | -0.24 | -0.34 | -0.27 | -0.29 |
| EPS Basic Continuous Ops | -0.46 | -0.24 | -0.34 | -0.27 | -0.30 |
| EPS Diluted Total Ops | -0.47 | -0.24 | -0.34 | -0.27 | -0.29 |
| EPS Diluted Continuous Ops | -0.46 | -0.24 | -0.34 | -0.27 | -0.30 |
| EPS Diluted Before Non-Recurring Items | -0.45 | -0.24 | -0.34 | -0.27 | N/A |
| EBITDA(a) | $-32,398 | $-19,903 | $-26,290 | $-17,237 | $-14,714 |